Nilotinib (monohydrochloride monohydrate) [923288-90-8]
Referência HY-10159A-100mg
Tamanho : 100mg
Marca : MedChemExpress
Nilotinib monohydrochloride monohydrate is a second generation tyrosine kinase inhibitor (TKI), is significantly potent against BCR-ABL, and is active against many BCR-ABL mutants.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
Nilotinib monohydrochloride monohydrate Chemical Structure
CAS No. : 923288-90-8
This product is a controlled substance and not for sale in your territory.
Based on 32 publication(s) in Google Scholar
Other Forms of Nilotinib monohydrochloride monohydrate:
- Nilotinib In-stock
- Nilotinib hydrochloride Obtenir un devis
-
Nilotinib monohydrochloride monohydrate purchased from MedChemExpress. Usage Cited in: Oncotarget. 2018 Apr 24;9(31):22158-22183. [Abstract]
- Primary tumors are dissected at the end of experiment and subjected to immunohistochemistry. Representative images of primary tumor sections stained with anti-PCNA (proliferation), anti-cleaved caspase 3 (apoptosis), and anti-CD31 (angiogenesis).
-
Nilotinib monohydrochloride monohydrate purchased from MedChemExpress. Usage Cited in: Leuk Lymphoma. 2015;56(8):2416-23. [Abstract]
- Cell cycle analysis of HT93A cells by flow cytometry. Cells are treated with 100 nM Nilotinib and 50 ng/mL G-CSF alone or in combination for 48 h before the cell cycle is analyzed. Nilotinib treatment increases the fraction of cells in G0/G1 phase and decreased the S+G2/M-phase fraction.